Ivan P. Gergel's Net Worth
$13.7 Million
Who is Ivan P. Gergel?
Ivan P. Gergel has an estimated net worth of $13.7 Million. This is based on reported shares across multiple companies, which include NEKTAR THERAPEUTICS, FOREST LABORATORIES INC, Corium International, Inc., Neurotrope, Inc., Endo International plc, ENDO HEALTH SOLUTIONS INC., and INDEVUS PHARMACEUTICALS INC.
SEC CIK
Ivan P. Gergel's CIK is 0001328288
Past Insider Trading and Trends
2014 was Ivan P. Gergel's most active year for acquiring shares with 9 total transactions. Ivan P. Gergel's most active month to acquire stocks was the month of November. 2014 was Ivan P. Gergel's most active year for disposing of shares, totalling 24 transactions. Ivan P. Gergel's most active month to dispose stocks was the month of January. 2013 saw Ivan P. Gergel paying a total of $2,181,470.82 for 164,235 shares, this is the most they've acquired in one year. In 2014 Ivan P. Gergel cashed out on 384,194 shares for a total of $7,264,132.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEKTAR THERAPEUTICS (NKTR) Snapshot price: $1.12
SVP & Chief Medical OfficerIvan P. Gergel owns 56,553 units of Common Stock which is worth $63,339.36. In the year 2014 Ivan P. Gergel filed a total of 19 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.03% | 14.98K |
$44.23 | -$222,123.06 | 56.55K |
Nov 15 - Nov 16
| |||
Form 4
|
—
|
0
|
$17.59 | -$1,309,639.68 | 41.58K |
Scheduled
|
Sep 29 - Oct 2
| ||
Form 4
| -4.58% | -2.00K |
$19.32 | -$38,582.04 | 41.58K |
Aug 16
| |||
Form 4
|
—
|
0
|
$16.07 | -$552,495.20 | 43.57K |
Scheduled
|
Jul 18
| ||
Form 4
|
—
|
0
|
$16.06 | -$452,634.55 | 43.57K |
Scheduled
|
Jul 11 - Jul 12
| ||
Form 4
| -3.22% | -1.45K |
$19.55 | -$28,347.50 | 43.57K |
May 16
| |||
Form 4
| -3.13% | -1.46K |
$13.14 | -$19,144.98 | 45.02K |
Feb 16
| |||
Form 4
| +75.53% | 20K |
—
|
—
| 46.48K |
Dec 13
| |||
Form 4
| -3.10% | -848.00 |
$13.96 | -$11,838.08 | 26.48K |
Nov 16
| |||
Form 4
| -5.81% | -1.69K |
$17.56 | -$29,588.60 | 27.33K |
Aug 16
| |||
Form 4
| +986.19% | 15K |
—
|
—
| 16.52K |
Jul 14
| |||
Form 4
| +117.87% | 818 |
$13.58 | -$5,866.43 | 1.51K |
May 16 - May 17
| |||
Form 4
|
∞
| 694 |
$11.92 | -$6,627.39 | 694 |
Feb 16 - Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FOREST LABORATORIES INC No price found
Sr VP - Chief Sci. OfficerIvan P. Gergel owns 15,000 units of Common Stock.acquired a total of 78,250 shares in FOREST LABORATORIES INC at a cost of $1,592,021.00, Ivan also disposed a total of 48,250 shares of FOREST LABORATORIES INC equalling to $2,366,360.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Dec 6
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Dec 6
| |||
Form 4
|
—
|
0
|
$46.16 | -$468,113.50 |
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
$30.67 | -$306,226.00 | 1.5K |
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corium International, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neurotrope, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Endo International plc (ENDPQ) Snapshot price: $0.0008
EVP, R&D and CSOIvan P. Gergel owns 27,649 units of Ordinary Shares which is worth $22.12. In the year 2014 Ivan P. Gergel filed a total of 1 filing.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$51.80 | -$3,126,818.21 | 27.65K |
Mar 10
| |||
| No matching records found | |||||||||